Differential role of monocyte subsets in atherosclerosis

M Hristov1, C Weber

  • 1Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany. mihail.hristov@med.uni-muenchen.de

Thrombosis and Haemostasis
|September 9, 2011
PubMed

Insights

Monocytes play a key role in atherosclerosis development. This review details monocyte subset functions in arterial inflammation, plaque rupture, and tissue repair in mice and humans.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Atherosclerosis Research

Background:

  • Endothelial dysfunction and arterial wall inflammation are primary drivers of atherosclerosis.
  • Emerging research highlights the sequential involvement of distinct monocyte subsets in atherosclerotic pathology.

Purpose of the Study:

  • To review major monocyte subpopulations in mice and humans.
  • To detail their phenotype, function, and recruitment in atherosclerosis.
  • To examine their roles in angiogenesis and tissue regeneration post-plaque rupture.

Main Methods:

  • Literature review focusing on monocyte subsets in atherosclerosis.
  • Comparative analysis of monocyte populations in mouse and human models.
  • Examination of functional roles in disease progression and repair.

Main Results:

  • Identification and characterization of key monocyte subpopulations involved in atherosclerosis.
  • Elucidation of their distinct roles in arterial inflammation and plaque development.
  • Understanding their contribution to neovascularization and tissue healing following plaque rupture.

Conclusions:

  • Monocyte subsets exhibit diverse functions critical to atherosclerosis pathogenesis.
  • Targeting specific monocyte populations may offer therapeutic strategies for cardiovascular disease.
  • Further research into monocyte biology is essential for advancing atherosclerosis treatment.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...